89bio, Inc. Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value
89bio, Inc. had Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value of $16.81 million as of 2021-09-30, per its 10-Q filed 2021-11-12.
Discontinued › Notes › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Additional Disclosures
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue · last filed 2021-11-12
- 2021-09-30: Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value $16.81M.
- 2021-06-30: Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value $16.18M.
- 2021-03-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value $22.66M.
- 2020-12-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value $25.92M.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value |
|---|---|
| 2021-09-30 | $16.81M 10-Q · filed 2021-11-12 |
| 2021-06-30 | $16.18M 10-Q · filed 2021-08-13 |
| 2021-03-31 | $22.66M 10-Q · filed 2021-05-14 |
| 2020-12-31 | $25.92M 10-Q · filed 2021-11-12 |
| 2020-09-30 | $28.65M 10-Q · filed 2020-11-13 |
| 2020-06-30 | $21.22M 10-Q · filed 2020-08-13 |
| 2020-03-31 | $28.11M 10-Q · filed 2020-05-13 |
| 2019-12-31 | $30.35M 10-Q · filed 2020-11-13 |